Science Explorer Interactive view Map
Topic · Occupational Therapy

Safe Handling of Antineoplastic Drugs

Safe Handling of Antineoplastic Drugs is a research topic within Occupational Therapy. Science Explorer counts 6.2k research works in it since 1950. 15.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the occupational exposure of health care workers to antineoplastic drugs, highlighting issues such as surface contamination, biological and environmental monitoring, use of closed-system protective devices, and the assessment of genotoxic effects. The papers also discuss the adherence to safety guidelines and the impact on reproductive health. The research aims to improve practices and reduce risks associated with handling antineoplastic drugs in healthcare settings.

  • Antineoplastic Drugs
  • Occupational Exposure
  • Health Care Workers
  • Surface Contamination
  • Biological Monitoring
  • Closed-System Device
  • Genotoxic Effects
  • Pharmacy Personnel
  • Environmental Monitoring
  • Safety Guidelines
Research works
6.2k
fractional, since 1950
In the world top 10%
944
per year above
Top-10% rate
15.2%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+6%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Safe Handling of Antineoplastic Drugs research?

By volume, the United States and France publish the most (245 and 141 works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 245 works
  2. 2 France 141 works
  3. 3 China 56 works
  4. 4 India 52 works
  5. 5 Japan 52 works
  6. 6 Spain 51 works
  7. 7 Brazil 46 works
  8. 8 United Kingdom 41 works
  9. 9 Netherlands 35 works
  10. 10 Germany 32 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 32.6%France: 18.8%China: 7.5%India: 6.9%6 others listed: 34.2%33%largest
United States245 · 32.6%France141 · 18.8%China56 · 7.5%India52 · 6.9%6 others listed256 · 34.2%

Shares of the rows listed above, not of the whole node.

Which institutions lead Safe Handling of Antineoplastic Drugs research?

By volume in 2022–2025, International Pharmaceutical Federation publishes the most Safe Handling of Antineoplastic Drugs research, followed by Mohammed V University and Inserm.

By volume, 2022–2025

  1. 1 International Pharmaceutical FederationNetherlands 11 works
  2. 2 Mohammed V UniversityMorocco 5 works
  3. 3 InsermFrance 5 works
  4. 4 University of North Carolina at Chapel HillUnited States 4 works
  5. 5 KU LeuvenBelgium 3 works
  6. 6 Edinburgh Napier UniversityUnited Kingdom 3 works
  7. 7 American Pharmacists AssociationUnited States 3 works
  8. 8 Universidade do PortoPortugal 3 works
  9. 9 Centre National de la Recherche ScientifiqueFrance 3 works
  10. 10 Centre Hospitalier Universitaire de LilleFrance 3 works

Who are the leading researchers in Safe Handling of Antineoplastic Drugs?

The most-cited researchers publishing on Safe Handling of Antineoplastic Drugs include Robert P. Rapp.

  1. 1 Robert P. Rapp United States 1.4k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

Where is Safe Handling of Antineoplastic Drugs research done?

The largest centres of Safe Handling of Antineoplastic Drugs research in 2022–2025 are Paris (France), Tokyo (Japan), Madrid (Spain) and London (United Kingdom). Among places with at least 20 works in it, it is an unusually large share of all research in Paris.

Largest cities, 2022–2025

  1. 1 Paris France 30 works
  2. 2 Tokyo Japan 15 works
  3. 3 Madrid Spain 15 works
  4. 4 London United Kingdom 13 works
  5. 5 The Hague Netherlands 12 works
  6. 6 New York United States 11 works
  7. 7 Riyadh Saudi Arabia 11 works
  8. 8 São Paulo Brazil 10 works
  9. 9 Seoul South Korea 10 works
  10. 10 Beijing China 10 works

Where it is the local speciality

  1. ParisFR · 30.2 works3.1×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Safe Handling of Antineoplastic Drugs than the world average.

See Safe Handling of Antineoplastic Drugs on the map

Is Safe Handling of Antineoplastic Drugs research growing?

Output in 2018–2022 was 6% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Safe Handling of Antineoplastic Drugs.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.